BioStock: DanCann Pharma aims for commercial breakthrough

Danish pharma company DanCann Pharma’s mission is to give patients without existing treatment options a better life through medical cannabis and cannabinoids. During its first year as a listed company, important steps have been taken and DanCann is now planning for a commercial breakthrough in 2022. BioStock has taken a closer look at the company’s report for the third quarter.

Read the full article about DanCann Pharma at biostock.se:

https://www.biostock.se/en/2021/12/dancann-pharma-aims-for-commercial-breakthrough/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/